UNITED STATES

 SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  January 30, 2015

 

Axcelis Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-30941

 

34-1818596

(State or other jurisdiction

 

(Commission

 

(IRS Employer

of incorporation)

 

File Number)

 

Identification No.)

 

108 Cherry Hill Drive, Beverly, Massachusetts

 

01915

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code:  (978) 787-4000

 

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o        Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o        Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o        Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o        Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 1.01 Entry into a Material Definitive Agreement.

 

Closing of Property Sale and Entry into Lease.  Effective on January 30, 2015, Axcelis Technologies, Inc. (“Axcelis” or the “Company”) sold the Company’s headquarters building at 108 Cherry Hill Drive, located on approximately 37 acres in Beverly, Massachusetts (the “Property”) to Beverly Property Owner LLC, an affiliate of Middleton Partners of Northbrook, Illinois (“Middleton”) under a Real Estate Sale Agreement dated October 3, 2014.  Under this sale, the Company received a purchase price of $49 million, of which approximately $15 million was applied to discharge a mortgage on the property.

 

Also effective on January 30, 2015, as part of the closing, the Company and Middleton entered into a Lease Agreement pursuant to which Axcelis will lease the Property for a 22 year term, with the right to extend up to an additional 25 years. The Lease provides for an annual rent of $4.7 million, $4.825 million and $5.36 million in years one, two and three, respectively.  The rent in subsequent years reflects an annual increase of 2%, until year 11, when the rent will decrease by 6%, and then continue with an annual increase of 2% in years 12-22.  The Lease contains “triple net” terms, which means that the Company will remain responsible for all expenses associated with the Property, including but not limited to maintenance, property taxes, insurance and facilities expense.  The Lease grants a right of first offer to the Company in the event that the landlord under the Lease desires to sell the Property.

 

Amendment of Credit Facility.  The Company has a revolving credit facility with Silicon Valley Bank (the “Bank”) dated October 31, 2013. Under this revolving credit facility, the Company has the ability to borrow up to $10.0 million on a revolving basis during its two year term. The Company’s ability to borrow under this line of credit is limited to 80% of the then current amount of qualified accounts receivable. Effective February 2, 2015, the Company and the Bank entered into a Second Amendment to the 2013 Loan and Security Agreement, which amended and restated a minimum adjusted net income covenant to eliminate a requirement for the quarter ended December 31, 2014 and adjusted this covenant for future periods. All other terms of the Loan and Security Agreement remain in effect.

 

Item 1.02 Termination of a Material Definitive Agreement.

 

On February 2, 2015, in connection with the closing of the sale of the Property, the Company terminated the Business Loan Agreement dated July 5, 2013 with Northern Bank & Trust Company by paying off the outstanding principal and accrued interest under that agreement.  Under the terminated agreement, the Company had received a term loan of $15.0 million due in July 2016, secured by the Property, as defined above.  The mortgage on the Property was released in connection with the termination.  In accordance with the Business Loan Agreement, Axcelis paid a 2% fee on the approximately $14.4 million principal prepayment.

 

Item 2.01 Completion of Acquisition or Disposition of Assets.

 

The disclosure in the first paragraph of Item 1.01 above is incorporated herein by reference.

 

Item 2.02 Results of Operations and Financial Condition.

 

On February 5, 2014, Axcelis Technologies, Inc. (the “Company”) issued a press release regarding its financial results for the quarter ended December 31, 2014.  The Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.

 

Item 9.01   Financial Statements and Exhibits.

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press Release dated February 5, 2015. Filed herewith.

 

2



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: February 5, 2015

 

Axcelis Technologies, Inc.

 

 

 

 

 

By:

/s/ KEVIN J. BREWER

 

 

 

Kevin J. Brewer

 

 

 

Executive Vice President

 

 

 

and Chief Financial Officer

 

3


Exhibit 99.1

 

News Release

 

AXCELIS ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2014

 

Purion H Momentum Drives 254% Increase in Systems Revenue

 

BEVERLY, Mass. — February 5, 2015—Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2014. Recent highlights include:

 

·                  Revenues of $62.5 million, a 62% increase over the third quarter.

 

·                  System sales of $29.9 million, a 254% increase over the third quarter.

 

·                  The Company returned to profitability with net income of $0.2 million or $0.00 per share compared to a net loss of $4.7 million or ($0.04) per share in the third quarter.

 

·                  Significant order activity for the Purion™ platform across DRAM, FLASH and foundry market segments.

 

·                  Closed a $49M sale leaseback agreement, generating net proceeds of approximately $34M after mortgage payoff.

 

The Company reported fourth quarter revenue of $62.5 million, compared to $38.5 million for the third quarter of 2014. Operating profit for the quarter was $0.4 million, compared to a $5.4 million loss for the third quarter. Net income for the quarter was $0.2 million, or $0.00 per share. This compares to a net loss for the third quarter of 2014 of $4.7 million, or ($0.04) per share. This included $2.3 million of restructuring charges. Cash and cash equivalents were $30.8 million at December 31, 2014 compared with $32.5 million at September 30, 2014.

 

For the full year 2014, the Company reported revenue of $203.1 million, compared with $195.6 million for the full year 2013. Net loss for the year was $11.3 million or ($0.10) per share. This compares to net loss for the full year 2013 of $17.1 million or ($0.16) per share.

 

Chairman and CEO Mary Puma said, “In the fourth quarter, we exceeded company guidance and analyst consensus estimates. Significant revenue growth was driven by the rapid adoption of the Purion H high current implanter. We expect the continued momentum of the Purion H will drive an increase in system sales in the first quarter.” She added, “The introduction of the Purion H high current implanter and the Purion M medium current implanter has opened an additional 85% of the market, giving Axcelis access to 100% of the nearly $1B ion implant market.”

 



 

Fourth Quarter and Full Year 2014 Conference Call

 

The Company will host a conference call today at 5:00 pm ET to discuss results for the fourth quarter and full year 2014. The call will be available to interested listeners via an audio webcast that can be accessed through the Investors page of Axcelis’ website at www.axcelis.com, or by dialing 1.888.680.0865 (1.617.213.4853 outside North America).  Participants calling into the conference call will be requested to provide the company name, Axcelis Technologies, and pass code: 44096419. Webcast replays will be available for 30 days following the call.

 

Safe Harbor Statement

 

This press release and the conference call contain forward-looking statements under the SEC safe harbor provisions. These statements, which include our guidance for future financial performance, are based on management’s current expectations and should be viewed with caution. They are subject to various risks and uncertainties, many of which are outside the control of the Company, including the timing of orders and shipments, the conversion of orders to revenue in any particular quarter, or at all, the continuing demand for semiconductor equipment, relative market growth, continuity of business relationships with and purchases by major customers, competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and global economic, political and financial conditions. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.

 

About Axcelis:

 

Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 35 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

 

Company Contacts

 

Investor Relations:

Doug Lawson
978.787.9552

 

Editorial/Media:

Maureen Hart
978.787.4266

 



 

Axcelis Technologies, Inc.

Consolidated Statements of Operations

(In thousands, except per share amounts)

(Unaudited)

 

 

 

Three months ended
December 31,

 

Twelve months ended
December 31,

 

 

 

2014

 

2013

 

2014

 

2013

 

Revenue:

 

 

 

 

 

 

 

 

 

Product

 

$

57,076

 

$

51,436

 

$

179,246

 

$

169,587

 

Services

 

5,454

 

7,138

 

23,805

 

26,045

 

Total revenue

 

62,530

 

58,574

 

203,051

 

195,632

 

Cost of revenue:

 

 

 

 

 

 

 

 

 

Product

 

39,639

 

31,702

 

113,285

 

106,678

 

Services

 

4,094

 

5,592

 

19,602

 

21,019

 

Total cost of revenue

 

43,733

 

37,294

 

132,887

 

127,697

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

18,797

 

21,280

 

70,164

 

67,935

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Research and development

 

7,481

 

8,899

 

33,533

 

34,756

 

Sales and marketing

 

5,310

 

5,031

 

20,713

 

21,159

 

General and administrative

 

5,602

 

6,306

 

23,958

 

25,471

 

Gain on sale of dry strip assets and intellectual property

 

 

 

 

(1,167

)

Restructuring charges

 

(27

)

 

2,621

 

2,334

 

Total operating expenses

 

18,366

 

20,236

 

80,825

 

82,553

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from operations

 

431

 

1,044

 

(10,661

)

(14,618

)

 

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

 

Interest income

 

27

 

36

 

32

 

44

 

Interest expense

 

(257

)

(149

)

(1,069

)

(457

)

Other, net

 

249

 

(402

)

1,531

 

(1,073

)

Total other income (expense)

 

19

 

(515

)

494

 

(1,486

)

 

 

 

 

 

 

 

 

 

 

Income (loss) before income taxes

 

450

 

529

 

(10,167

)

(16,104

)

 

 

 

 

 

 

 

 

 

 

Income tax provision (benefit)

 

285

 

(85

)

1,099

 

1,040

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

165

 

$

614

 

$

(11,266

)

$

(17,144

)

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share

 

 

 

 

 

 

 

 

 

Basic

 

$

0.00

 

$

0.01

 

$

(0.10

)

$

(0.16

)

Diluted

 

$

0.00

 

$

0.01

 

$

(0.10

)

$

(0.16

)

 

 

 

 

 

 

 

 

 

 

Shares used in computing net loss per share:

 

 

 

 

 

 

 

 

 

Basic weighted average common shares

 

112,218

 

109,746

 

111,450

 

108,869

 

Diluted weighted average common shares

 

117,251

 

114,906

 

111,450

 

108,869

 

 



 

Axcelis Technologies, Inc.

Consolidated Balance Sheets

(In thousands, except per share amounts)

(Unaudited)

 

 

 

December 31,
2014

 

December 31,
2013

 

ASSETS

 

 

 

 

 

Cash and cash equivalents

 

$

30,753

 

$

46,290

 

Accounts receivable, net

 

42,794

 

36,587

 

Inventories, net

 

104,063

 

95,789

 

Prepaid expenses and other assets

 

18,755

 

22,052

 

Property, plant and equipment, net

 

30,464

 

32,006

 

Restricted cash

 

825

 

825

 

Total assets

 

$

227,654

 

$

233,549

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Accounts payable

 

$

21,605

 

$

19,451

 

Accrued compensation

 

4,232

 

4,845

 

Warranty

 

1,527

 

1,428

 

Income taxes

 

196

 

417

 

Deferred revenue

 

7,231

 

4,709

 

Debt

 

14,530

 

15,000

 

Other liabilities

 

9,981

 

11,697

 

Total liabilities

 

59,302

 

57,547

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, $0.001 par value, 30,000 shares authorized; none issued or outstanding

 

 

 

Common stock, $0.001 par value, 300,000 shares authorized; 112,849 shares issued and 112,729 shares outstanding at December 31, 2014; 110,225 shares issued and 110,105 shares outstanding at December 31, 2013

 

113

 

110

 

Additional paid-in capital

 

519,068

 

510,992

 

Treasury stock, at cost, 120 shares at December 31, 2014 and December 31, 2013

 

(1,218

)

(1,218

)

Accumulated deficit

 

(350,887

)

(339,621

)

Accumulated other comprehensive income

 

1,276

 

5,739

 

Total stockholders’ equity

 

168,352

 

176,002

 

Total liabilities and stockholders’ equity

 

$

227,654

 

$

233,549

 

 



 

Axcelis Technologies, Inc.

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

 

 

Twelve months ended

 

 

 

December 31,

 

 

 

2014

 

2013

 

Cash flows from operating activities

 

 

 

 

 

Net loss

 

$

(11,266

)

$

(17,144

)

Adjustments to reconcile net loss to net cash used for operating activities:

 

 

 

 

 

Depreciation and amortization

 

4,586

 

5,075

 

Gain on sale of dry strip assets and intellectual property

 

 

(1,167

)

Deferred taxes

 

1,266

 

(1,465

)

Stock-based compensation expense

 

4,812

 

4,337

 

Provision for inventory reserves

 

1,817

 

2,562

 

Changes in operating assets & liabilities:

 

 

 

 

 

Accounts receivable

 

(7,069

)

(11,528

)

Inventories

 

(12,280

)

2,209

 

Prepaid expenses and other assets and liabilities

 

(1,051

)

(3,181

)

Accounts payable and other liabilities

 

772

 

7,308

 

Deferred revenue

 

2,577

 

(2,181

)

Income taxes

 

(212

)

133

 

Net cash used for operating activities

 

(16,048

)

(15,042

)

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

Proceeds from sale of dry strip assets and intellectual property

 

 

1,200

 

Expenditures for property, plant, and equipment

 

(1,017

)

(821

)

Decrease in restricted cash

 

 

106

 

Net cash (used for) provided by investing activities

 

(1,017

)

485

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

Increase in restricted cash

 

 

(825

)

Financing fees and other expenses

 

(115

)

(560

)

Proceeds from exercise of stock options

 

2,894

 

1,669

 

Proceeds from Employee Stock Purchase Plan

 

447

 

436

 

Proceeds from issuance of Term Loan

 

 

15,000

 

Principal payments on Term Loan

 

(470

)

 

Net cash provided by financing activities

 

2,756

 

15,720

 

Effect of exchange rate changes on cash and cash equivalents

 

(1,228

)

141

 

Net (decrease) increase in cash and cash equivalents

 

(15,537

)

1,304

 

Cash and cash equivalents at beginning of period

 

46,290

 

44,986

 

Cash and cash equivalents at end of period

 

$

30,753

 

$

46,290